Skip to main content
Picture Florian Schmidt and Jan Hasenauer

News categories: Honors & Funding

Two ERC Consolidator Grants for ImmunoSensation members

The EU is putting up millions in funding for immunology, mathematical life sciences and pure mathematics projects

Another big success for the University of Bonn in securing grants from the European Research Council (ERC), with three researchers receiving an ERC Consolidator Grant. Two of those grants go to ImmunoSensation2 researchers: Professor Jan Hasenauer of the LIMES Institute and Professor Florian I. Schmidt of the Institute for Innate Immunity.

Using simulation technology in oncology


Every tumor is unique and its response to therapies is determined by innumerable changes within cells and their interactions. “Therapies tailored to specific mutations of a tumor can effectively extend, and in
some cases even save, the lives of cancer patients,” reports Professor Jan Hasenauer of the Life and Medical Sciences Institute (LIMES) at the University of Bonn. Newly emerging immunotherapy approaches in particular hold tremendous potential. Until now, decisions as to which therapy to pursue for a given individual have been made on the basis of simple statistical models, but these do not allow for a reliable prediction of therapeutic success.

Professor Hasenauer is therefore working to develop simulation models for predicting tumor treatments in his project “INTEGRATE”, which has received roughly 1.9 million euros in funding. The project concentrates on breast, stomach and kidney cancers—which account for approximately 30% of cancer cases in Europe. To improve the prediction accuracy, Professor Hasenauer will use machine learning to render more data available for training the simulation models. These data sets will come from clinical practice, clinical studies and projects like The Cancer Genome Atlas. “My vision is to create digital twins of the cancer patients in order to achieve better treatment outcomes,” he explains.

Professor Hasenauer studied Technical Cybernetics at the University of Stuttgart, where he earned a doctorate in engineering. After working at Helmholtz Munich and the Technical University of Munich, he became Professor of Mathematics and Life Sciences at the University of Bonn in 2017. In 2022 he then assumed a preeminent Schlegel professorship, created as part of the Excellence Initiative. Professor Hasenauer is a member of the Transdisciplinary Research Areas Modelling and Life and Health, and of the Hausdorff Center for Mathematics and ImmunoSensation2 Clusters of Excellence.

Controlling inflammation


When pathogens invade the human body, the immune system responds with inflammation to fight them off. Autoinflammatory diseases like inflammatory bowel disease, however, are characterized by the immune system turning against the body itself, triggering inflammation without any apparent reason, which causes pain and long-term damage. “To treat such diseases, we need to understand how the body halts or prevents inflammation on its own accord,” says Professor Florian Schmidt of the Institute of Innate Immunity at the Universityof Bonn and University Hospital Bonn.

Professor Schmidt will investigate the foundations of the immune system in his project DEFLAMMATION, which is funded by an ERC Consolidator Grant with around 2 million euros. “My hypothesis is that complex signaling networks interpret information which can prevent or regulate the inflammation response,” he elaborates. Understanding these elusive processes requires new cell biology tools, which Schmidt intendsto develop and utilize in the project. A member of the Transdisciplinary Research Area Life & Health and of the ImmunoSensation2 Cluster of Excellence, Professor Schmidt commented that“The ERC Grant funding will allow me to explore an entirely new field of research and develop new methods that will have relevance in many other areas.”

Florian I. Schmidt studied Biochemistry at the Technical University of Munich before completing a PhD in Virology at ETH Zurich. He worked as a postdoc at the Massachusetts Institute of Technology (MIT) in the US and came back to Germany as an Emmy Noether Group Leader at the University of Bonn. In 2022, he was appointed as a professor at the Institute of Innate Immunity.

ERC Consolidator Grants


The European Research Council (ERC) awards ERC Consolidator Grants annually to fund projects of outstanding early-career researchers whose high-level scientific work is on par with international peers. The Grantfunding is provided to enable building solid, independent research teams. For more information visit https://erc.europa.eu/apply-grant/consolidator-grant

Full press release at the University of Bonn: https://www.uni-bonn.de/en/news/220-2023

Contact

Prof. Dr. Jan Hasenauer
LIMES Institute
University of Bonn
Phone: +49 228 73 69446
Email: jan.hasenauer@uni-bonn.de

Prof. Dr. Florian Schmidt
Institute of Innate Immunity
University of Bonn
Phone: +49 228 28751124
Email: fschmidt@uni-bonn.de

Related news

Sieglinde Tyczka und Frederick Tyczka-Christoph zu Besuch in der Bonner Universitäts-Augenklinik. - von links: Prof. Dr. Uwe Reuter, Vorstandsvorsitzender und Ärztlicher Vorstand des UKB, Frederick Tyczka-Christoph, Sieglinde Tyczka, Prof. Dr. Frank G. Holz, Direktor der Augenklinik am UKB.

News categories: Honors & Funding

One Million Euros for Restoring Vision in Age-Related Macular Degeneration

The Tyczka family of entrepreneurs is supporting research into restoring vision in patients with age-related macular degeneration (AMD) with a donation of one million euros. The funding will support the research project “AI-supported optimisation of vision restoration using retinal implants” at the Department of Ophthalmology at Bonn University Hospital (UKB). The aim of the project is to further develop and optimise the application of innovative retinal implant technology, which recently received European CE marking as a medical device.
View entry
25 Millionen Euro für die Bonner KI-Krebsforschung: (v.l.) Prof. Dr. Bernd Weber, Prof. Dr. Michael Hölzel, Prof. Dr. Jürgen Bajorath und Prof. Dr. Uwe Reuter, beim Auftakt von AI4CancerCure.NRW in der Staatskanzlei Nordrhein-Westfalen.

News categories: Honors & Funding

€25 Million for AI-Powered Cancer Research in Bonn

University Hospital Bonn (UKB), the University of Bonn and the Lamarr Institute for Machine Learning and Artificial Intelligence are using funding from the state of North Rhine-Westphalia to establish a joint research infrastructure. The aim is to use AI to design and optimize potential cancer therapeutics and subsequently test them in the laboratory. Minister-President Hendrik Wüst and Minister of Science Ina Brandes presented the funding commitment today at the State Chancellery of North Rhine-Westphalia.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry

Back to the news overview